These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12856922

  • 1. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives.
    Martinez A, Gil C, Castro A, Bruno AM, Pérez C, Prieto C, Otero J.
    Antivir Chem Chemother; 2003 Mar; 14(2):107-14. PubMed ID: 12856922
    [Abstract] [Full Text] [Related]

  • 2. Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity.
    Martinez A, Gil C, Castro A, Pérez C, Prieto C, Otero J.
    Bioorg Med Chem; 2003 May 29; 11(11):2395-402. PubMed ID: 12735985
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
    Martinez A, Esteban AI, Castro A, Gil C, Conde S, Andrei G, Snoeck R, Balzarini J, De Clercq E.
    J Med Chem; 1999 Apr 08; 42(7):1145-50. PubMed ID: 10197958
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.
    Zhan P, Liu X, De Clercq E.
    Curr Med Chem; 2008 Apr 08; 15(15):1529-40. PubMed ID: 18537628
    [Abstract] [Full Text] [Related]

  • 6. Chlorophenylmethyl benzothiadiazine dioxides derivatives: potent human cytomegalovirus inhibitors.
    Martinez A, Gil C, Perez C, Castro A, Prieto C, Otero J.
    Bioorg Med Chem Lett; 1999 Nov 01; 9(21):3133-6. PubMed ID: 10560739
    [Abstract] [Full Text] [Related]

  • 7. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis.
    Martinez A, Gil C, Abasolo MI, Castro A, Bruno AM, Perez C, Prieto C, Otero J.
    J Med Chem; 2000 Aug 24; 43(17):3218-25. PubMed ID: 10966740
    [Abstract] [Full Text] [Related]

  • 8. Anti-HIV-1 activity of benzothiadiazine dioxide.
    Martinez A, Gil C, Castro A, Perez C, Witvrouw M, Pannecouque C, Balzarini J, De Clercq E.
    Antivir Chem Chemother; 2001 Nov 24; 12(6):347-51. PubMed ID: 12018679
    [Abstract] [Full Text] [Related]

  • 9. Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques.
    Gil C, Dorronsoro I, Castro A, Martinez A.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1919-21. PubMed ID: 15780633
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S, García-Aparicio C, Andrei G, Snoeck R, Balzarini J, Camarasa MJ, Velázquez S.
    J Med Chem; 2009 Mar 26; 52(6):1582-91. PubMed ID: 19226140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Fitch DM, Evans KA, Chai D, Duffy KJ.
    Org Lett; 2005 Nov 24; 7(24):5521-4. PubMed ID: 16288546
    [Abstract] [Full Text] [Related]

  • 15. Discovery of a novel series of inhibitors of human cytomegalovirus primase.
    Cushing TD, Adrian J, Chen X, DiMaio H, Doughan B, Flygare J, Liang L, Mayorga V, Miao S, Mellon H, Peterson MG, Powers JP, Spector F, Stein C, Wright M, Xu D, Ye Q, Jaen J.
    Bioorg Med Chem Lett; 2006 Sep 15; 16(18):4879-83. PubMed ID: 16814545
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Porcari AR, Devivar RV, Kucera LS, Drach JC, Townsend LB.
    J Med Chem; 1998 Apr 09; 41(8):1252-62. PubMed ID: 9548815
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.